FPD-93462-83720
3 vaccinations
10 coded responses
21 check-ins
10 free-text entries
2 call cases
- Sex
- Male
- Age at first dose
- 31-35
- ZIP prefix
- 786 / TX
- Registered
- 2021-01-10
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-08
Dose 1 — Moderna
-
2021-01-10
Registered in v-safe
-
2021-01-10
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-01-10
Report sent to call center — days 1–6 daily, dose 1Be unable to work · Be unable to do your normal daily activities1 call case(s)
- 2021-01-15
-
2021-01-22
Survey response — day 14, dose 1MedDRA: Lymphadenopathy — Feeling: GoodFree text: Swollen gland in armpit near injecrion site.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-29
-
2021-02-05
Survey response — day 28, dose 1MedDRA: Lymphadenopathy, Unevaluable event — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Symptoms: Axillary lymphadenopathy ipsilateral of the arm in which I which I got the shot persists. · Healthcare visit (other): I am having a biopsy this coming Tuesday.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-05
Report sent to call center — day 28, dose 1Get care from a doctor or other healthcare professional1 call case(s)
-
2021-02-12
Dose 2 — Moderna
-
2021-02-12
Survey response — day 0, dose 2MedDRA: Lymphadenopathy — Feeling: Fair · Site: PainFree text: Axillary lymphadenopathy persists since January 20MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-13
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-02-14
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Swelling · Headache · Be unable to workAdult check-in
- 2021-02-15
-
2021-02-16
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: Good · Site: PainFree text: Axillary lymphadenopathy persistsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-18
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: GoodFree text: Axillary lymphadenopathy persistsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-19
Survey response — day 7, dose 2MedDRA: Lymphadenopathy — Feeling: GoodFree text: Axillary lymphadenopathy persistsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-28
Survey response — day 14, dose 2MedDRA: Lymphadenopathy — Feeling: GoodFree text: UNILATERAL axillary lymphadenopathy persists.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-05
Survey response — day 21, dose 2MedDRA: Axillary lymphadenectomy — Feeling: GoodFree text: UNILATERAL axillary lymphadenopathy persistsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-12
Survey response — day 28, dose 2MedDRA: Lymphadenopathy — Feeling: GoodFree text: Unilateral axillary lymphadenopathy persists.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-29
- 2021-05-14
- 2021-05-26
- 2021-08-13
-
2022-10-05
Dose 3 — Pfizer-BioNTech
-
2022-10-11
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: Good · Site: PainFree text: Generalized lymphadenopathy in axillary of injection siteMedDRA releases: 2024-11 · check-in free text available
- 2022-10-12
- 2022-10-19
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-08 | Moderna | |
| 2 | 2021-02-12 | Moderna | |
| 3 | 2022-10-05 | Pfizer-BioNTech | No |
Call center
2 call center cases
1 unsuccessful · 1 priority 2/3 (triaged and no follow up)
1 wait over 3 months for a first call
Free text
Release 2 — day 14, dose 1
Symptoms: Swollen gland in armpit near injecrion site.
Release 3 — day 28, dose 1
Symptoms: Axillary lymphadenopathy ipsilateral of the arm in which I which I got the shot persists.
Healthcare visit (other): I am having a biopsy this coming Tuesday.
Release 4 — day 0, dose 2
Systemic reaction (other): Axillary lymphadenopathy persists since January 20
Release 4 — days 1–6 daily, dose 2
Systemic reaction (other): Axillary lymphadenopathy persists
Systemic reaction (other): Axillary lymphadenopathy persists
Release 4 — day 7, dose 2
Systemic reaction (other): Axillary lymphadenopathy persists
Release 4 — day 14, dose 2
Symptoms: UNILATERAL axillary lymphadenopathy persists.
Release 5 — day 21, dose 2
Symptoms: UNILATERAL axillary lymphadenopathy persists
Release 5 — day 28, dose 2
Symptoms: Unilateral axillary lymphadenopathy persists.
Release 12 — days 1–6 daily, dose 3
Systemic reaction (other): Generalized lymphadenopathy in axillary of injection site
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Unevaluable event | ✓ | ✓ | ✓ |
| SD | Axillary lymphadenectomy | ✓ | ✓ | ✓ |
| SD | Lymphadenopathy | ✓ | ✓ | ✓ |
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release